Page last updated: 2024-09-05

ergolide and Leukemia

ergolide has been researched along with Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Darbandi, A; Gharehbaghian, A; Hamzeloo-Moghadam, M; Karami, A; Mashati, P; Takhviji, V; Yami, A1

Other Studies

1 other study(ies) available for ergolide and Leukemia

ArticleYear
Ergolide, a potent sesquiterpene lactone induces cell cycle arrest along with ROS-dependent apoptosis and potentiates vincristine cytotoxicity in ALL cell lines.
    Journal of ethnopharmacology, 2020, May-10, Volume: 253

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Humans; Inhibitory Concentration 50; Inula; Lactones; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Sesquiterpenes; Vincristine

2020